GLYCOTOPE
DEAD

Serial Number

85246561

Owner

Glycotope GmbH

Attorney

LEIGH ANN LINDQUIST

Filing Date

Feb 18, 2011

Add to watchlist:

No watchlists yet
View on USPTO

GLYCOTOPE Trademark

Serial Number: 85246561

GLYCOTOPE is a trademark filed by Glycotope GmbH on February 18, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Glycotope GmbH (13 trademarks)

Robert-Rössle-Str. 10

Entity Type: 99

Trademark Details

Filing Date

February 18, 2011

Registration Date

Not Registered

Published for Opposition

November 1, 2011

Goods & Services

Pharmaceutical preparations and veterinary preparations for pets and livestock, namely, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic sugar for medical use; food for babies; medical plasters; materials for dressings, namely, wound dressings, burn dressings, and surgery dressings; materials for dental filling, namely, fillings for teeth, and impression materials for dental purposes; disinfectants for hygienic purposes, medical instruments, sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; medicines for human purposes and veterinary purposes for pets and livestock, namely, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; nutritional supplements, namely, carbohydrates for medical purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes; cultures of cells, particularly human cells for medical or veterinary purposes; medicinal drinks; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives all for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes, namely, nutritional supplements; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements

Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering substances and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and related preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic reagents, other than for medical purposes, namely, for use in biochemistry, clinical chemistry and microbiology; carbohydrates for use in the manufacture of food or nutraceuticals; cultures of microorganisms, other than for medical or veterinary use, and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms or cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of proteins and peptides; expression systems for proteins and peptides comprising cells, particularly human cells and microorganisms, suitable for expressing engineered or glycosylated proteins or peptides, or capable of providing optimized glycosylation activity; milk ferments for chemical purposes

Medical services and veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services, namely, vermin extermination for agriculture, pest control services for agriculture, horticulture or forestry; pharmaceutical advice; performance of medical services featuring clinical examinations; nutrition counseling; health consultancy

Medical laboratories, namely, consumer-authorized clinical laboratory testing services that report results directly to the patient; scientific and technological services and research and designer services relating thereto, namely, in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveying; conducting scientific surveys in the field of biotechnology, bacterial and cell engineering, protein production, glycosylation; scientific research and development, namely, in the field of bacteriology, cytology, antibody technology, chemistry, immunology, cosmetics of expression systems in the nature of production or glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control for others; research and development of new products; research and development of new technologies for others in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; technical and scientific consultancy in relation to biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of production or glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines and microorganisms, antibody-engineering, optimized biological therapeutics, nutraceuticals, food and nutritional supplements; scientific research, quality control, technical consultancy and product development in the field of proteins, antibodies, microorganisms and cells; scientific research and development in the field of microorganisms and cells

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 21, 2015 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 21, 2015 ABN2
ASSIGNED TO EXAMINER
Jan 31, 2015 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2015 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2015 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 22, 2015 ZZZX
ASSIGNED TO EXAMINER
Jan 22, 2015 DOCK
CASE RETURNED TO EXAMINATION
Dec 30, 2014 OTHE
NOTICE OF ALLOWANCE CANCELLED
Dec 29, 2014 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Nov 26, 2014 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Nov 26, 2014 PCBG
ASSIGNED TO PETITION STAFF
Nov 19, 2014 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Nov 10, 2014 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 6, 2014 EXRA
SOU EXTENSION 5 GRANTED
Jun 5, 2014 EX5G
SOU EXTENSION 5 FILED
Jun 4, 2014 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 4, 2014 EEXT
ASSIGNED TO EXAMINER
Apr 10, 2014 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 10, 2013 EXRA
SOU EXTENSION 4 GRANTED
Dec 9, 2013 EX4G
SOU EXTENSION 4 FILED
Dec 5, 2013 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 5, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 18, 2013 EXRA
SOU EXTENSION 3 GRANTED
Jul 17, 2013 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 15, 2013 AITU
SOU EXTENSION 3 FILED
Jun 19, 2013 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 19, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 22, 2012 EXRA
SOU EXTENSION 2 GRANTED
Dec 20, 2012 EX2G
SOU EXTENSION 2 FILED
Dec 20, 2012 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 20, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 23, 2012 EXRA
SOU EXTENSION 1 GRANTED
Jun 21, 2012 EX1G
SOU EXTENSION 1 FILED
Jun 21, 2012 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 21, 2012 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2011 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 27, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 26, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2011 CNRT
ASSIGNED TO EXAMINER
May 19, 2011 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 12, 2011 AMPX
ASSIGNED TO LIE
May 4, 2011 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 27, 2011 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2011 NWOS
NEW APPLICATION ENTERED
Feb 22, 2011 NWAP